Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Rheumatic Diseases Clinics of North America|February 1, 1995
Refractory osteoarthritis. Differential diagnosis and therapyB F Mandell, J LipaniThe American Journal of Pediatric Hematology/Oncology|February 1, 1993
Recombinant human GM-CSF treatment of neutropenia in glycogen storage disease-1bD Hurst, L Kilpatrick, J Becker, et al.The Journal of Rheumatology|May 22, 2001
Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapiesT G Woodworth, D E Furst, V Strand, et al.Blood|May 1, 1991
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantationJ Nemunaitis, C D Buckner, F R Appelbaum, et al.The Journal of Rheumatology|July 24, 1998
Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trialD E Yocum, A M Solinger, J Tesser, et al.Journal of Clinical Immunology|March 1, 1996
Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various speciesE V Ruggieri, P J Bugelski, J M Kaplan, et al.Blood|September 25, 2001
Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBLH J Deeg, B R Blazar, B J Bolwell, et al.Pageof 1